Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
18 pending office actions • 16 clients • 18 examiners • 18 art units • 0 of 18 (0%) have an AI response strategy ready
Lavery, De Billy, LLP has 19 pending office actions in Biotechnology & Pharmaceuticals and 1576 career applications. The data shows a substantial historical application record together with a sizeable current examination workload in the same technical field.
The resolved allowance rate is 82.55%, while the average is 2.9 office actions per allowance. The first figure describes resolved allowance outcomes, and the second indicates the amount of office-action activity associated with allowed matters. Practitioners can use this combination to anticipate active prosecution demands, but should treat the historical measures as context rather than as a case-specific forecast.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (22%) |
| §103 only | 4 (22%) |
| Double-patenting + other | 1 (6%) |
| Multi-statute (no §101) | 9 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTALVO, CARLOS FERNANDO | 1 | 14.3% | -2.9% |
| FAYE, MAMADOU | 1 | 78.5% | +6.5% |
| ALSOMIRI, ISAM A | 1 | 66.8% | +23.2% |
| LIU, TRACY | 1 | 54.5% | +26.9% |
| MCFARLAND, KATHLEEN MAVOURNEEN | 1 | 59.9% | +12.5% |
| CASERTO, JULIA SHARON | 1 | 71.4% | +28.9% |
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.9% |
| ANDERSON, FOLASHADE | 1 | 35.3% | +37.0% |
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
| CUNNINGCHEN, KATHLEEN MARY | 1 | 62.5% | +60.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18615237 | METHOD, DEVICE, AND COMPUTER-READABLE MEDIUM FOR DISPATCHING A PLURALITY OF AGENTS TO A PLURALITY OF TASKS | ANDERSON, FOLASHADE | 32d overdue |
| 18558634 | BOOK PRINTING MANAGEMENT SYSTEM AND METHOD | ALLEN, WILLIAM J | 3d overdue |
| 17904677 | USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS | HEITMEIER, KENDALL NICOLE | 2d overdue |
| 19394215 | COLLABORATIVE FLOW EDITING SYSTEM AND METHOD | MONTALVO, CARLOS FERNANDO | — |
| 19206571 | METHOD AND A SYSTEM FOR GENERATING STABLE ULTRASHORT PULSES OF XUV AND SOFT X-RAY RADIATION | FAYE, MAMADOU | — |
| 18768745 | POROUS MATERIAL AND PROCESS | LIU, TRACY | — |
| 18662285 | LADDER SAFETY DEVICE | MCFARLAND, KATHLEEN MAVOURNEEN | — |
| 18703858 | SYSTEM FOR REPLENISHING AN ON-BOARD POWER SOURCE FOR A PROPULSION SYSTEM ON A VEHICLE SUCH AS A WATERCRAFT AND PROCESS | CASERTO, JULIA SHARON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18615237 | METHOD, DEVICE, AND COMPUTER-READABLE MEDIUM FOR DISPATCHING A PLURALITY OF AGENTS TO A PLURALITY OF TASKS | ANDERSON, FOLASHADE | 32d overdue |
| 18588829 | PUTRESCINE SLOW-RELEASE TOPICAL FORMULATIONS | KASSA, TIGABU | 84d |
| 18857077 | A METHOD AND A SYSTEM FOR 3D SURFACE IMAGING | ALSOMIRI, ISAM A | — |
| 18768745 | POROUS MATERIAL AND PROCESS | LIU, TRACY | — |
| 18662285 | LADDER SAFETY DEVICE | MCFARLAND, KATHLEEN MAVOURNEEN | — |
| 18703858 | SYSTEM FOR REPLENISHING AN ON-BOARD POWER SOURCE FOR A PROPULSION SYSTEM ON A VEHICLE SUCH AS A WATERCRAFT AND PROCESS | CASERTO, JULIA SHARON | — |
| 18699854 | METHOD FOR CROSSLINKING HYALURONIC ACID USING RESONANT ACOUSTIC MIXING | SHIAO, YIH-HORNG | — |
| 18576567 | NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF | CUNNINGCHEN, KATHLEEN MARY | — |
| Art Unit | Apps |
|---|---|
| 3629 | 1 |
| 2884 | 1 |
| 3645 | 1 |
| 1614 | 1 |
| 3635 | 1 |
| 1789 | 1 |
| 1691 | 1 |
| 3623 | 1 |
| 1619 | 1 |
| 1646 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19394215 | COLLABORATIVE FLOW EDITING SYSTEM AND METHOD | Gemba Software Solutions Inc. | MONTALVO, CARLOS FERNANDO | 3629 | §101§103 | Non-Final OA | — | Pending | Nov 19, 2025 |
| 19206571 | METHOD AND A SYSTEM FOR GENERATING STABLE ULTRASHORT PULSES OF XUV AND SOFT X-RAY RADIATION | Institut National De La Recherche Scientifique | FAYE, MAMADOU | 2884 | §102§103 | Non-Final OA | — | Pending | May 13, 2025 |
| 18857077 | A METHOD AND A SYSTEM FOR 3D SURFACE IMAGING | Institut National De La Recherche Scientifique | ALSOMIRI, ISAM A | 3645 | §103 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18768745 | POROUS MATERIAL AND PROCESS | Groupe Ppd Inc. | LIU, TRACY | 1614 | §103§112 | Final Rejection | — | Pending | Jul 10, 2024 |
| 18662285 | LADDER SAFETY DEVICE | Delta Prevention Inc. | MCFARLAND, KATHLEEN MAVOURNEEN | 3635 | §102§103 | Non-Final OA | — | Pending | May 13, 2024 |
| 18703858 | SYSTEM FOR REPLENISHING AN ON-BOARD POWER SOURCE FOR A PROPULSION SYSTEM ON A VEHICLE SUCH AS A WATERCRAFT AND PROCESS | Cambria Geosciences Inc. | CASERTO, JULIA SHARON | 1789 | §102§103 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18699854 | METHOD FOR CROSSLINKING HYALURONIC ACID USING RESONANT ACOUSTIC MIXING | Studio Bioscience Inc. | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18615237 | METHOD, DEVICE, AND COMPUTER-READABLE MEDIUM FOR DISPATCHING A PLURALITY OF AGENTS TO A PLURALITY OF TASKS | Humanitas Solutions Inc. | ANDERSON, FOLASHADE | 3623 | §101§102§103 | Final Rejection | 32d overdue | Pending | Mar 25, 2024 |
| 18588829 | PUTRESCINE SLOW-RELEASE TOPICAL FORMULATIONS | Vivier Canada Inc. | KASSA, TIGABU | 1619 | §103 | Non-Final OA | 84d | Pending | Feb 27, 2024 |
| 18576567 | NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF | Valorisation Hsj, Limited Partnership | CUNNINGCHEN, KATHLEEN MARY | 1646 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18536140 | DEPLOYING RESOURCES IN A NETWORK | Solutions Humanitas Inc. | WILLIAMS, TRACY L | 2462 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18567915 | COMBINATION THERAPY FOR THE TREATMENT OF ENTERIC NEUROPATHIES | Transfert Plus, Limited Partnership | CHERNYSHEV, OLGA N | 1675 | §103DP | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18558634 | BOOK PRINTING MANAGEMENT SYSTEM AND METHOD | Imprimerie Gauvin Ltée | ALLEN, WILLIAM J | 3619 | §101§103§112 | Non-Final OA | 3d overdue | Pending | Nov 02, 2023 |
| 18492974 | METHOD AND SYSTEM FOR SINGLE-PIXEL IMAGING | Institut National De La Recherche Scientifique | LI, LARRY | 2881 | §103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18253465 | USE OF CARRAGEENAN AS A VISCOSITY-MODIFYING ADMIXTURE IN A FLOWABLE CEMENTITIOUS SUSPENSIONS | Socpra Sciences Et Genie S.E.C. | WEISS, PAMELA HL | 1732 | §103§112 | Non-Final OA | — | Pending | May 18, 2023 |
| 18030407 | LIVE BIOTHERAPEUTICS SECRETING SYNTHETIC BACTERIOPHAGES IN THE TREATMENT OF CANCER | Tatum Bioscience Inc. | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | 29d | Pending | Apr 05, 2023 |
| 17904677 | USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS | VAL-CHUM, LIMITED PARTNERSHIP | HEITMEIER, KENDALL NICOLE | 1621 | §103§112 | Non-Final OA | 2d overdue | Pending | Aug 19, 2022 |
| 17757570 | USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR THE TREATMENT OF ENTERIC NEUROPATHIES | Transfert Plus, Société En Commandite | NGUYEN, NGHI V | 1653 | §103 | Final Rejection | 8d | Pending | Jun 17, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial82.5% of resolved applications prosecuted by Lavery, De Billy, LLP were allowed, across 1,576 applications in USPTO records.
2.90 office actions per allowed application on average.
18 pending office actions as of October 2026, for 16 clients, before 18 examiners in 18 art units.
